Related Experiment Video
Updated: Aug 30, 2025

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Cardiovascular outcomes of transradial versus transfemoral percutaneous coronary intervention in End-Stage renal
Yasar Sattar1, Mohammed Faisaluddin2, Talal Almas3
1West Virginia University, Morgantown, WV, USA.
Insights
Transradial access (TR-PCI) significantly reduces mortality, bleeding, and transfusion needs compared to transfemoral access (TF-PCI) in patients with end-stage renal disease undergoing percutaneous coronary intervention.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Limited comparative data exists for transradial (TR) versus transfemoral (TF) access in percutaneous coronary intervention (PCI) for end-stage renal disease (ESRD) patients.
- ESRD patients represent a vulnerable population with potentially higher risks during PCI procedures.
Purpose of the Study:
- To compare cardiovascular outcomes between TR and TF access in ESRD patients undergoing PCI.
- To identify potential benefits of TR access in this specific patient group.
Main Methods:
- A systematic review and meta-analysis of online databases was conducted.
- Included studies compared outcomes of TR-PCI versus TF-PCI in ESRD patients.
- Key outcomes assessed included mortality, cerebrovascular accidents (CVA), myocardial infarction (MI), bleeding, transfusion, and cardiogenic shock (CS).
Main Results:
- Six studies comprising 7,607 patients (1,288 TR-PCI, 6,319 TF-PCI) were analyzed.
- TR-PCI was associated with significantly lower rates of mortality (OR 0.46), bleeding (OR 0.45), and transfusion (OR 0.52) compared to TF-PCI.
- No significant differences were observed in periprocedural MI, CS, or CVA between the two access methods.
Conclusions:
- Transradial access demonstrates a favorable safety profile in ESRD patients undergoing PCI.
- TR-PCI is associated with reduced mortality, bleeding, and transfusion requirements compared to TF-PCI in this population.
- These findings support the consideration of TR access for PCI in patients with end-stage renal disease.
Background:
Limited data is available on the comparison of outcomes of transradial (TR) and transfemoral (TF) access for percutaneous coronary intervention (PCI) in patients with end-stage stage renal disease (ESRD).
Methods:
Online databases were queried to compare cardiovascular outcomes among TR. and TF in ESRD patients. The outcomes assessed included differences in mortality, cerebrovascular accidents (CVA), periprocedural myocardial infarction (MI), bleeding, transfusion, and periprocedural cardiogenic shock (CS). Unadjusted odds ratios (OR) were calculated using a random-effect effect model.
Results:
A total of 6 studies including 7,607 patients (TR-PCI = 1,288; TF-PCI = 6,319) were included. The overall mean age was 67.7 years, while the mean age for TR-PCI and TF-PCI was 69.7 years and 67.9 years, respectively. TR-PCI was associated with lower incidence of mortality (OR 0.46 95 % CI 0.30-0.70, p < 0.05, I2 0.00 %), bleeding (OR 0.45 95 % CI 0.29, 0.68, p < 0.05, I2 3.48 %), and transfusion requirement (OR 0.52 95 % CI 0.40, 0.67, p < 0.05, I2 0.00 %) (Fig. 1). There were no differences among TR-PCI and TF-PCI for periprocedural MI, periprocedural CS, and CVA outcomes.
Conclusion:
TR access was associated with lower mortality, bleeding, and transfusion requirement as compared to TF access in patients with ESRD undergoing PCI.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
06:02Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Kidney Transplant I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Imaging Studies VII: Vascular Imaging
Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications